Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2127288rdf:typepubmed:Citationlld:pubmed
pubmed-article:2127288lifeskim:mentionsumls-concept:C0006751lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C0023733lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:2127288lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:2127288pubmed:issue11lld:pubmed
pubmed-article:2127288pubmed:dateCreated1991-4-9lld:pubmed
pubmed-article:2127288pubmed:abstractTextA variance-stabilizing transformation (VST) was applied to the linear regression of calibration standards of different drugs in plasma. This transformation involved the normalization of the dependent variable peak height or peak area ratio (Y), and the independent variable, plasma drug concentration (C). This transformation led to a constant variance in the regression error term across the measured concentration range and allowed the evaluation of the unbiased slope and y intercept with minimum variance. The utility of the VST procedure in comparison with the ordinary least squares (OLS) approach, routinely used in pharmaceutical studies for constructing calibration lines, is described. The principal advantage of the VST approach is allowing a lower minimum level of drug quantification while using a single calibration line over a wide range of drug concentrations. The VST method is especially useful to quantify drug plasma levels in pharmacokinetic evaluation of sustained-release dosage forms, where the precise quantification of low levels of drug is critical. The application of the VST method was explored and evaluated in comparison with the OLS method for pharmacokinetic assays of diltiazem, gallopamil, nitroglycerin, and nicotine.lld:pubmed
pubmed-article:2127288pubmed:languageenglld:pubmed
pubmed-article:2127288pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:citationSubsetIMlld:pubmed
pubmed-article:2127288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2127288pubmed:statusMEDLINElld:pubmed
pubmed-article:2127288pubmed:monthNovlld:pubmed
pubmed-article:2127288pubmed:issn0022-3549lld:pubmed
pubmed-article:2127288pubmed:authorpubmed-author:BialekJJlld:pubmed
pubmed-article:2127288pubmed:authorpubmed-author:GonzalezM AMAlld:pubmed
pubmed-article:2127288pubmed:authorpubmed-author:McLeanA MAMlld:pubmed
pubmed-article:2127288pubmed:authorpubmed-author:RuggirelloD...lld:pubmed
pubmed-article:2127288pubmed:authorpubmed-author:BanfieldCClld:pubmed
pubmed-article:2127288pubmed:issnTypePrintlld:pubmed
pubmed-article:2127288pubmed:volume79lld:pubmed
pubmed-article:2127288pubmed:ownerNLMlld:pubmed
pubmed-article:2127288pubmed:authorsCompleteYlld:pubmed
pubmed-article:2127288pubmed:pagination1005-8lld:pubmed
pubmed-article:2127288pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:meshHeadingpubmed-meshheading:2127288-...lld:pubmed
pubmed-article:2127288pubmed:year1990lld:pubmed
pubmed-article:2127288pubmed:articleTitleApplication of a variance-stabilizing transformation approach to linear regression of calibration lines.lld:pubmed
pubmed-article:2127288pubmed:affiliationDepartment of Biopharmaceutics and Pharmacokinetics, Schering-Plough Research, Miami, FL 33023.lld:pubmed
pubmed-article:2127288pubmed:publicationTypeJournal Articlelld:pubmed